Koers Alterola Biotech, Inc. Other OTC
Aandelen
ABTI
US02152V1035
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 35,27 mln. 32,98 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -6 mln. -5,61 mln. | Nettowinst (verlies) 2023 | -1 mln. -935K | EV/omzet 2022 | - |
Nettoschuld 2022 | 199K 186K | Nettoschuld 2023 | 1,41 mln. 1,31 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-26,2
x | K/w-verhouding 2023 |
-20,2
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 56,4% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18-05-22 |
Timothy Rogers
CHM | Chairman | 60 | 21-06-21 |
Colin Stott
COO | Chief Operating Officer | 57 | 21-06-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18-05-22 |
Nathan Thompson
BRD | Director/Board Member | - | 10-10-23 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |